HEADER HYDROLASE 22-SEP-11 3TX8 TITLE CRYSTAL STRUCTURE OF A SUCCINYL-DIAMINOPIMELATE DESUCCINYLASE (ARGE) TITLE 2 FROM CORYNEBACTERIUM GLUTAMICUM ATCC 13032 AT 2.97 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: SUCCINYL-DIAMINOPIMELATE DESUCCINYLASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SDAP DESUCCINYLASE; COMPND 5 EC: 3.5.1.18; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CORYNEBACTERIUM GLUTAMICUM; SOURCE 3 ORGANISM_TAXID: 1718; SOURCE 4 ATCC: 13032; SOURCE 5 GENE: DAPE, CGL1109, CG1260; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS PEPTIDASE, STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, KEYWDS 2 JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-BIOLOGY, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG),A.T.BRUNGER, AUTHOR 2 T.C.TERWILLIGER,R.J.READ,P.D.ADAMS,M.LEVITT,G.F.SCHRODER REVDAT 8 06-DEC-23 3TX8 1 REMARK REVDAT 7 20-SEP-23 3TX8 1 REMARK REVDAT 6 01-FEB-23 3TX8 1 REMARK SEQADV REVDAT 5 17-JUL-19 3TX8 1 REMARK LINK REVDAT 4 08-NOV-17 3TX8 1 REMARK REVDAT 3 10-OCT-12 3TX8 1 JRNL REVDAT 2 28-MAR-12 3TX8 1 JRNL REVDAT 1 26-OCT-11 3TX8 0 JRNL AUTH A.T.BRUNGER,D.DAS,A.M.DEACON,J.GRANT,T.C.TERWILLIGER, JRNL AUTH 2 R.J.READ,P.D.ADAMS,M.LEVITT,G.F.SCHRODER JRNL TITL APPLICATION OF DEN REFINEMENT AND AUTOMATED MODEL BUILDING JRNL TITL 2 TO A DIFFICULT CASE OF MOLECULAR-REPLACEMENT PHASING: THE JRNL TITL 3 STRUCTURE OF A PUTATIVE SUCCINYL-DIAMINOPIMELATE JRNL TITL 4 DESUCCINYLASE FROM CORYNEBACTERIUM GLUTAMICUM. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 68 391 2012 JRNL REFN ISSN 0907-4449 JRNL PMID 22505259 JRNL DOI 10.1107/S090744491104978X REMARK 2 REMARK 2 RESOLUTION. 2.97 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.7.1 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MLHL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.97 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.54 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.870 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 16098 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.240 REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.240 REMARK 3 FREE R VALUE TEST SET COUNT : 1649 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.5477 - 6.7801 0.99 1359 163 0.2216 0.2159 REMARK 3 2 6.7801 - 5.3922 1.00 1257 153 0.2313 0.2512 REMARK 3 3 5.3922 - 4.7137 1.00 1220 154 0.1949 0.2156 REMARK 3 4 4.7137 - 4.2842 0.99 1213 129 0.1840 0.2223 REMARK 3 5 4.2842 - 3.9779 1.00 1197 135 0.2116 0.2350 REMARK 3 6 3.9779 - 3.7438 0.99 1199 131 0.2512 0.2829 REMARK 3 7 3.7438 - 3.5567 0.99 1185 138 0.2611 0.2551 REMARK 3 8 3.5567 - 3.4021 0.99 1198 117 0.2783 0.3026 REMARK 3 9 3.4021 - 3.2713 0.98 1154 133 0.3134 0.3394 REMARK 3 10 3.2713 - 3.1585 0.99 1172 135 0.3329 0.4001 REMARK 3 11 3.1585 - 3.0599 0.98 1140 130 0.3826 0.4425 REMARK 3 12 3.0599 - 2.9725 0.98 1155 131 0.3619 0.3683 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.83 REMARK 3 K_SOL : 0.34 REMARK 3 B_SOL : 62.72 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.710 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.120 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 91.33 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 99.67 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 18.00320 REMARK 3 B22 (A**2) : 18.00320 REMARK 3 B33 (A**2) : -36.00640 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2801 REMARK 3 ANGLE : 0.625 3809 REMARK 3 CHIRALITY : 0.047 430 REMARK 3 PLANARITY : 0.002 505 REMARK 3 DIHEDRAL : 11.380 1011 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A AND (RESSEQ 10:175 OR RESSEQ 293:369) REMARK 3 ORIGIN FOR THE GROUP (A): 7.0580 45.9960 191.6712 REMARK 3 T TENSOR REMARK 3 T11: 0.4078 T22: 0.8337 REMARK 3 T33: 0.3887 T12: -0.0300 REMARK 3 T13: 0.0415 T23: 0.1304 REMARK 3 L TENSOR REMARK 3 L11: 2.4425 L22: 2.3110 REMARK 3 L33: 2.1614 L12: -0.3795 REMARK 3 L13: 0.1714 L23: 0.5488 REMARK 3 S TENSOR REMARK 3 S11: 0.1903 S12: -0.2721 S13: -0.0156 REMARK 3 S21: 0.2171 S22: -0.1181 S23: -0.0426 REMARK 3 S31: -0.3184 S32: -0.2443 S33: 0.0007 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN A AND (RESSEQ 176:292) REMARK 3 ORIGIN FOR THE GROUP (A): -5.4184 36.5320 158.8134 REMARK 3 T TENSOR REMARK 3 T11: 0.2353 T22: 0.5285 REMARK 3 T33: 0.5478 T12: -0.0442 REMARK 3 T13: 0.0371 T23: 0.0774 REMARK 3 L TENSOR REMARK 3 L11: 1.1638 L22: 2.1730 REMARK 3 L33: 0.8309 L12: 0.0513 REMARK 3 L13: 1.2164 L23: -0.1429 REMARK 3 S TENSOR REMARK 3 S11: -0.1797 S12: -0.2428 S13: -0.3350 REMARK 3 S21: -0.1778 S22: 0.2896 S23: 0.0783 REMARK 3 S31: 0.4140 S32: 0.0325 S33: 0.0244 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. A MET-INHIBITION PROTOCOL WAS USED REMARK 3 FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. REMARK 3 THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 2. ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B REMARK 3 FACTORS. ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U REMARK 3 FACTORS. 3. PHOSPHATE (PO4) AND CHLORIDE (CL) FROM THE REMARK 3 CRYSTALLIZATION SOLUTION HAVE BEEN MODELED IN THE SOLVENT REMARK 3 STRUCTURE. 4. THE STRUCTURE WAS SOLVED BY A COMBINATION OF REMARK 3 MOLECULAR REPLACEMENT USING PHASER AND DEN REFINEMENT IN CNS, IN REMARK 3 CONJUCTION WITH MODELLER, AUTOBUILD AND EXPERIMENTAL PHASING REMARK 3 WITH SE MAD PHASES 5.THE REFINEMENT WAS RESTRAINED WITH THE MAD REMARK 3 PHASES. REMARK 4 REMARK 4 3TX8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1000068033. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAY-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.41 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91162,0.97919,0.97936 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE JANUARY 30, 2009 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16179 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.970 REMARK 200 RESOLUTION RANGE LOW (A) : 29.543 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.09500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.97 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 1.24800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT + REMARK 200 MAD REMARK 200 SOFTWARE USED: PHASER 2.3.0, CNS 1.3 REMARK 200 STARTING MODEL: 1VGY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 72.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 43.1% POLYETHYLENE GLYCOL 400, 0.20M REMARK 280 SODIUM CHLORIDE, 0.1M NA/K PHOSPHATE PH 6.41, ADDITIVE: 0.006 M REMARK 280 ZINC CHLORIDE, NANODROP, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+1/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 242.78333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 121.39167 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 182.08750 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 60.69583 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 303.47917 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 242.78333 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 121.39167 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 60.69583 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 182.08750 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 303.47917 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -52.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 0.866025 0.000000 -41.45050 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 71.79437 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 303.47917 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 ASN A 2 REMARK 465 SER A 3 REMARK 465 ASN A 4 REMARK 465 GLN A 6 REMARK 465 PRO A 7 REMARK 465 GLY A 8 REMARK 465 LEU A 9 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 11 -72.27 -74.12 REMARK 500 LEU A 12 -4.77 74.44 REMARK 500 SER A 29 129.05 -37.73 REMARK 500 ASN A 57 -123.05 57.50 REMARK 500 ARG A 66 34.51 -92.67 REMARK 500 LEU A 68 153.66 59.40 REMARK 500 ALA A 69 -95.32 -74.61 REMARK 500 PRO A 82 124.96 -36.35 REMARK 500 ASP A 93 76.85 56.91 REMARK 500 MSE A 104 -52.05 88.36 REMARK 500 ALA A 139 142.57 -38.54 REMARK 500 ASP A 140 64.52 -68.82 REMARK 500 HIS A 141 3.59 -150.69 REMARK 500 PRO A 259 -2.61 -59.35 REMARK 500 SER A 342 -168.64 -69.26 REMARK 500 PHE A 343 13.99 53.15 REMARK 500 ALA A 344 -71.48 -52.55 REMARK 500 ARG A 347 47.00 -74.23 REMARK 500 ASP A 348 47.59 -178.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 376512 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 1. THE CONSTRUCT WAS EXPRESSED WITH AN N-TERMINAL PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS CLEAVED WITH TEV PROTEASE LEAVING REMARK 999 GLY(0) FOLLOWED BY THE TARGET SEQUENCE. 2. DNA SEQUENCING OF THE REMARK 999 CLONED CONSTRUCT REVEALS TWO AMINO ACID SUBSTITUTIONS (E4N AND K6Q) REMARK 999 AND ONE AMINO ACID DELETION (L5DEL), WHEN COMPARED TO THE AVAILABLE REMARK 999 GENBANK SEQUENCE (NP_600337.1) FROM CORYNEBACTERIUM GLUTAMICUM 534 REMARK 999 (ATCC 13032). DBREF 3TX8 A 1 369 UNP Q59284 DAPE_CORGL 1 369 SEQADV 3TX8 GLY A 0 UNP Q59284 EXPRESSION TAG SEQADV 3TX8 ASN A 4 UNP Q59284 GLU 4 SEE REMARK 999 SEQADV 3TX8 A UNP Q59284 LEU 5 SEE REMARK 999 SEQADV 3TX8 GLN A 6 UNP Q59284 LYS 6 SEE REMARK 999 SEQRES 1 A 369 GLY MSE ASN SER ASN GLN PRO GLY LEU ASP LEU LEU GLY SEQRES 2 A 369 ASP PRO ILE VAL LEU THR GLN ARG LEU VAL ASP ILE PRO SEQRES 3 A 369 SER PRO SER GLY GLN GLU LYS GLN ILE ALA ASP GLU ILE SEQRES 4 A 369 GLU ASP ALA LEU ARG ASN LEU ASN LEU PRO GLY VAL GLU SEQRES 5 A 369 VAL PHE ARG PHE ASN ASN ASN VAL LEU ALA ARG THR ASN SEQRES 6 A 369 ARG GLY LEU ALA SER ARG VAL MSE LEU ALA GLY HIS ILE SEQRES 7 A 369 ASP THR VAL PRO ILE ALA ASP ASN LEU PRO SER ARG VAL SEQRES 8 A 369 GLU ASP GLY ILE MSE TYR GLY CYS GLY THR VAL ASP MSE SEQRES 9 A 369 LYS SER GLY LEU ALA VAL TYR LEU HIS THR PHE ALA THR SEQRES 10 A 369 LEU ALA THR SER THR GLU LEU LYS HIS ASP LEU THR LEU SEQRES 11 A 369 ILE ALA TYR GLU CYS GLU GLU VAL ALA ASP HIS LEU ASN SEQRES 12 A 369 GLY LEU GLY HIS ILE ARG ASP GLU HIS PRO GLU TRP LEU SEQRES 13 A 369 ALA ALA ASP LEU ALA LEU LEU GLY GLU PRO THR GLY GLY SEQRES 14 A 369 TRP ILE GLU ALA GLY CYS GLN GLY ASN LEU ARG ILE LYS SEQRES 15 A 369 VAL THR ALA HIS GLY VAL ARG ALA HIS SER ALA ARG SER SEQRES 16 A 369 TRP LEU GLY ASP ASN ALA MSE HIS LYS LEU SER PRO ILE SEQRES 17 A 369 ILE SER LYS VAL ALA ALA TYR LYS ALA ALA GLU VAL ASN SEQRES 18 A 369 ILE ASP GLY LEU THR TYR ARG GLU GLY LEU ASN ILE VAL SEQRES 19 A 369 PHE CYS GLU SER GLY VAL ALA ASN ASN VAL ILE PRO ASP SEQRES 20 A 369 LEU ALA TRP MSE ASN LEU ASN PHE ARG PHE ALA PRO ASN SEQRES 21 A 369 ARG ASP LEU ASN GLU ALA ILE GLU HIS VAL VAL GLU THR SEQRES 22 A 369 LEU GLU LEU ASP GLY GLN ASP GLY ILE GLU TRP ALA VAL SEQRES 23 A 369 GLU ASP GLY ALA GLY GLY ALA LEU PRO GLY LEU GLY GLN SEQRES 24 A 369 GLN VAL THR SER GLY LEU ILE ASP ALA VAL GLY ARG GLU SEQRES 25 A 369 LYS ILE ARG ALA LYS PHE GLY TRP THR ASP VAL SER ARG SEQRES 26 A 369 PHE SER ALA MSE GLY ILE PRO ALA LEU ASN PHE GLY ALA SEQRES 27 A 369 GLY ASP PRO SER PHE ALA HIS LYS ARG ASP GLU GLN CYS SEQRES 28 A 369 PRO VAL GLU GLN ILE THR ASP VAL ALA ALA ILE LEU LYS SEQRES 29 A 369 GLN TYR LEU SER GLU MODRES 3TX8 MSE A 73 MET SELENOMETHIONINE MODRES 3TX8 MSE A 96 MET SELENOMETHIONINE MODRES 3TX8 MSE A 104 MET SELENOMETHIONINE MODRES 3TX8 MSE A 202 MET SELENOMETHIONINE MODRES 3TX8 MSE A 251 MET SELENOMETHIONINE MODRES 3TX8 MSE A 329 MET SELENOMETHIONINE HET MSE A 73 8 HET MSE A 96 8 HET MSE A 104 8 HET MSE A 202 8 HET MSE A 251 8 HET MSE A 329 8 HET PO4 A 401 5 HET CL A 402 1 HETNAM MSE SELENOMETHIONINE HETNAM PO4 PHOSPHATE ION HETNAM CL CHLORIDE ION FORMUL 1 MSE 6(C5 H11 N O2 SE) FORMUL 2 PO4 O4 P 3- FORMUL 3 CL CL 1- HELIX 1 1 ASP A 14 ASP A 24 1 11 HELIX 2 2 GLU A 32 ASN A 45 1 14 HELIX 3 3 MSE A 104 ALA A 119 1 16 HELIX 4 4 ASN A 143 HIS A 152 1 10 HELIX 5 5 PRO A 153 ALA A 157 5 5 HELIX 6 6 ARG A 194 GLY A 198 5 5 HELIX 7 7 ALA A 201 LYS A 204 5 4 HELIX 8 8 LEU A 205 TYR A 215 1 11 HELIX 9 9 ASP A 262 LEU A 274 1 13 HELIX 10 10 GLN A 299 GLY A 310 1 12 HELIX 11 11 ASP A 322 ALA A 328 1 7 HELIX 12 12 VAL A 353 GLU A 369 1 17 SHEET 1 A 8 GLU A 52 PHE A 56 0 SHEET 2 A 8 ASN A 59 ARG A 63 -1 O LEU A 61 N PHE A 54 SHEET 3 A 8 ASP A 127 TYR A 133 -1 O LEU A 130 N ALA A 62 SHEET 4 A 8 ARG A 71 HIS A 77 1 N LEU A 74 O THR A 129 SHEET 5 A 8 LEU A 160 LEU A 163 1 O LEU A 160 N MSE A 73 SHEET 6 A 8 ALA A 333 PHE A 336 1 O LEU A 334 N LEU A 163 SHEET 7 A 8 ILE A 171 ALA A 173 -1 N GLU A 172 O ASN A 335 SHEET 8 A 8 ILE A 314 ALA A 316 1 O ARG A 315 N ALA A 173 SHEET 1 B 3 ARG A 90 VAL A 91 0 SHEET 2 B 3 ILE A 95 TYR A 97 -1 O TYR A 97 N ARG A 90 SHEET 3 B 3 GLN A 350 PRO A 352 -1 O CYS A 351 N MSE A 96 SHEET 1 C 4 GLY A 230 SER A 238 0 SHEET 2 C 4 LEU A 248 PHE A 257 -1 O ARG A 256 N GLY A 230 SHEET 3 C 4 GLY A 177 HIS A 186 -1 N LEU A 179 O PHE A 255 SHEET 4 C 4 ILE A 282 ALA A 290 -1 O GLU A 283 N THR A 184 SHEET 1 D 2 GLU A 219 ILE A 222 0 SHEET 2 D 2 LEU A 225 ARG A 228 -1 O LEU A 225 N ILE A 222 LINK C VAL A 72 N MSE A 73 1555 1555 1.33 LINK C MSE A 73 N LEU A 74 1555 1555 1.33 LINK C ILE A 95 N MSE A 96 1555 1555 1.33 LINK C MSE A 96 N TYR A 97 1555 1555 1.33 LINK C ASP A 103 N MSE A 104 1555 1555 1.33 LINK C MSE A 104 N LYS A 105 1555 1555 1.33 LINK C ALA A 201 N MSE A 202 1555 1555 1.33 LINK C MSE A 202 N HIS A 203 1555 1555 1.33 LINK C TRP A 250 N MSE A 251 1555 1555 1.33 LINK C MSE A 251 N ASN A 252 1555 1555 1.33 LINK C ALA A 328 N MSE A 329 1555 1555 1.33 LINK C MSE A 329 N GLY A 330 1555 1555 1.33 CISPEP 1 LEU A 87 PRO A 88 0 -1.78 SITE 1 AC1 4 HIS A 191 ASN A 243 ARG A 256 TRP A 320 SITE 1 AC2 2 PHE A 318 GLY A 319 CRYST1 82.901 82.901 364.175 90.00 90.00 120.00 P 65 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012063 0.006964 0.000000 0.00000 SCALE2 0.000000 0.013929 0.000000 0.00000 SCALE3 0.000000 0.000000 0.002746 0.00000